David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Malibu Boats
MBUU
$523M
| $725K | ﹤0.01% |
18,323
-25,246
| -58% | -$1.04M |
|
|
MDR
2752
CALL
DELISTED
McDermott International
MDR
| $725K | ﹤0.01% |
97,400
-42,877
| -31% | -$353K |
|
2753
ESCO Technologies
ESE
$7.34B
| $724K | ﹤0.01% |
10,804
+7,368
| +214% | +$493K |
|
2754
Morningstar
MORN
$7.97B
| $724K | ﹤0.01% |
5,746
-40
| -0.7% | -$4.81K |
|
2755
PUT
Southern Company
SO
$103B
| $724K | ﹤0.01% |
+14,000
| New | +$686K |
|
|
PDCE
2756
PUT
DELISTED
PDC Energy, Inc.
PDCE
| $724K | ﹤0.01% |
17,800
-13,100
| -42% | -$478K |
|
2757
PUT
National Health Investors
NHI
$3.6B
| $723K | ﹤0.01% |
9,200
+5,400
| +142% | +$429K |
|
2758
CALL
Accenture
ACN
$111B
| $722K | ﹤0.01% |
4,100
+300
| +8% | +$47.1K |
|
2759
Lear
LEA
$8.28B
| $722K | ﹤0.01% |
5,318
-15,348
| -74% | -$2.25M |
|
|
USAK
2760
PUT
DELISTED
USA Truck Inc
USAK
| $722K | ﹤0.01% |
+50,000
| New | +$848K |
|
2761
CALL
Progressive
PGR
$129B
| $721K | ﹤0.01% |
+10,000
| New | +$685K |
|
2762
PUT
Wolfspeed
WOLF
$1.4B
| $721K | ﹤0.01% |
12,600
+6,800
| +117% | +$349K |
|
2763
Regal Rexnord
RRX
$11B
| $720K | ﹤0.01% |
8,801
-13,268
| -60% | -$1.05M |
|
|
HA
2764
DELISTED
Hawaiian Holdings, Inc.
HA
| $717K | ﹤0.01% |
27,306
+18,111
| +197% | +$526K |
|
2765
PUT
Wheaton Precious Metals
WPM
$70.9B
| $715K | ﹤0.01% |
30,000
-185,000
| -86% | -$3.94M |
|
|
UBA
2766
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $715K | ﹤0.01% |
34,663
+10,336
| +42% | +$215K |
|
2767
CALL
Weibo
WB
$1.73B
| $713K | ﹤0.01% |
11,500
-23,700
| -67% | -$1.47M |
|
2768
Littelfuse
LFUS
$10.6B
| $711K | ﹤0.01% |
3,898
-23,348
| -86% | -$4.31M |
|
|
RFP
2769
CALL
DELISTED
Resolute Forest Products Inc.
RFP
| $711K | ﹤0.01% |
90,000
-25,000
| -22% | -$209K |
|
|
NLSN
2770
CALL
DELISTED
Nielsen Holdings plc
NLSN
| $710K | ﹤0.01% |
30,000
-10,000
| -25% | -$259K |
|
2771
Chubb
CB
$133B
| $707K | ﹤0.01% |
5,044
-700
| -12% | -$93.1K |
|
2772
Moelis & Co
MC
$4.98B
| $707K | ﹤0.01% |
17,000
-175,825
| -91% | -$7.51M |
|
|
LTC
2773
LTC Properties
LTC
$2.18B
| $706K | ﹤0.01% |
15,421
-19,161
| -55% | -$861K |
|
|
ELVT
2774
DELISTED
Elevate Credit, Inc.
ELVT
| $705K | ﹤0.01% |
162,526
+71,147
| +78% | +$320K |
|
2775
Glacier Bancorp
GBCI
$6.14B
| $703K | ﹤0.01% |
+17,553
| New | +$737K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.